To sniff out possible safety problems with drugs and medical devices, the Food and Drug Administration is going to start mining millions of medical records. Not yours, but maybe the ones your hospital has. Nancy Marshall Genzer reports.
For the first time, cancer doctors and researchers have put the abstracts of their cancer studies online in advance of their major annual meeting later this month. And you can bet Wall Street has been poring over the reports. Janet Babin has the story.
Cancer has replaced heart disease as the number one killer of people in their 40's and 50's, and this means growth in oncology drug sales. Janet Babin reports that by 2012, the cancer drug market is set to grow to $80 billion.
Victims left deformed when their mothers took the drug Thalidomide are in Germany to launch the latest stage in a multibillion-dollar campaign to get more compensation from the company that marketed the drug 50 years ago. Stephen Beard reports
A study out today finds that many scientific studies leave out details about who paid for the research.
Janet Babin learns from the author of the study that such omissions prevent a realistic evaluation of the research.
Pharmaceutical companies face expiring patents on many blockbuster drugs, with few new medicines in the pipeline to replace them. So the industry's trying creative ways to make money. Some say too creative. Nancy Marshall Genzer reports.